Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Deoxynucleotide Triphosphates (dNTPs) Market by Type (Liquid dNTPs, Solid dNTPs), By Application (Pharmaceutical, Research Institutions) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Deoxynucleotide Triphosphates (dNTPs) Market by Type (Liquid dNTPs, Solid dNTPs), By Application (Pharmaceutical, Research Institutions) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 332167 4200 Chemical & Material 377 211 Pages 5 (48)
                                          

Market Overview:


The global deoxynucleotide triphosphates (dNTPs) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising demand for nucleic acids from pharmaceutical and research institutions, and increasing R&D expenditure on nucleic acid synthesis. Based on type, the global dNTPs market is segmented into liquid dNTPs and solid dNTPs. The liquid dNTPs segment is projected to register a higher CAGR during the forecast period, owing to its growing demand from pharmaceutical and research institutions. By application, the pharmaceutical segment dominates the global market for dNTPS followed by research institutions.


Global Deoxynucleotide Triphosphates (dNTPs) Industry Outlook


Product Definition:


Deoxynucleotide triphosphates (dNTPs) are the building blocks of DNA. They are used in the replication of DNA, and are also necessary for repairing damaged DNA.


Liquid dNTPs:


Liquid dNTPs is a ready-to-use solution of dNTPs in water. It offers several advantages such as it is cost effective, ecofriendly and has no added preservatives. The product also eliminates the risk associated with transportation and handling of chemicals which may be unstable due to high moisture content.


Solid dNTPs:


Solid dNTPs are manufactured by the double decomposition of orthophosphoric acid (H3PO4) and is used as a component in the preparation of samples for polymerase chain reaction (PCR) or other nucleic acid based detection methods. Solid dNTPs have high purity, which helps to ensure that there is no contamination with other components during sample preparation.


Application Insights:


The pharmaceutical segment dominated the global deoxynucleotide triphosphates (dNTPs) market in terms of revenue in 2017. The growth can be attributed to the increasing use of dNTPs for manufacturing DNA and RNA samples for drug development. Furthermore, an increase in research activities pertaining to gene therapy has also positively influenced industry growth.


Research institutions are anticipated to register a significant CAGR during the forecast period owing to increased funding from government agencies, such as National Institutes of Health (NIH), which is used for genetic analysis and other related research studies. Moreover, an increase in R&D spending by companies involved with diagnostics & therapeutics is expected to boost industry growth over the forecast period.


Regional Analysis:


North America dominated the global deoxynucleotide triphosphates market in 2017. The presence of well-established healthcare infrastructure, high disposable income, and increasing investments by pharmaceutical companies for drug discovery are some of the major factors contributing to this dominance. In addition, growing focus on advanced technologies for disease diagnosis is expected to drive the demand over the forecast period.


Asia Pacific is anticipated to witness a lucrative growth rate during the forecast period owing to rising healthcare expenditure and improving economic conditions in emerging countries such as India and China. Moreover, an increase in government initiatives aimed at improving public health services is likely to boost regional product demand during the projected time frame.


Growth Factors:


  • Increasing demand for nucleic acids in life science research
  • Growing application of dNTPs in diagnostics and therapeutics
  • Rising investments in genomics and proteomics research
  • Technological advancements in dNTPs production process
  • Growing demand from emerging economies

Scope Of The Report

Report Attributes

Report Details

Report Title

Deoxynucleotide Triphosphates (dNTPs) Market Research Report

By Type

Liquid dNTPs, Solid dNTPs

By Application

Pharmaceutical, Research Institutions

By Companies

Thermo Scientific, Merck Millipore, Promega, Meridian Bioscience, Jena Bioscience, Takara Bio, NEB, Geneaid

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

211

Number of Tables & Figures

148

Customization Available

Yes, the report can be customized as per your need.


Global Deoxynucleotide Triphosphates (dNTPs) Market Report Segments:

The global Deoxynucleotide Triphosphates (dNTPs) market is segmented on the basis of:

Types

Liquid dNTPs, Solid dNTPs

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical, Research Institutions

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Scientific
  2. Merck Millipore
  3. Promega
  4. Meridian Bioscience
  5. Jena Bioscience
  6. Takara Bio
  7. NEB
  8. Geneaid

Global Deoxynucleotide Triphosphates (dNTPs) Market Overview


Highlights of The Deoxynucleotide Triphosphates (dNTPs) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Liquid dNTPs
    2. Solid dNTPs
  1. By Application:

    1. Pharmaceutical
    2. Research Institutions
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Deoxynucleotide Triphosphates (dNTPs) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Deoxynucleotide Triphosphates (dNTPs) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Deoxynucleotide triphosphates (dNTPs) are nucleotides that contain three phosphate groups. They are used in DNA and RNA synthesis, as well as other cellular processes.

Some of the major players in the deoxynucleotide triphosphates (dntps) market are Thermo Scientific, Merck Millipore, Promega, Meridian Bioscience, Jena Bioscience, Takara Bio, NEB, Geneaid.

The deoxynucleotide triphosphates (dntps) market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Deoxynucleotide Triphosphates (dNTPs) Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Deoxynucleotide Triphosphates (dNTPs) Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Deoxynucleotide Triphosphates (dNTPs) Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Deoxynucleotide Triphosphates (dNTPs) Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Deoxynucleotide Triphosphates (dNTPs) Market Size & Forecast, 2020-2028       4.5.1 Deoxynucleotide Triphosphates (dNTPs) Market Size and Y-o-Y Growth       4.5.2 Deoxynucleotide Triphosphates (dNTPs) Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Liquid dNTPs
      5.2.2 Solid dNTPs
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Pharmaceutical
      6.2.2 Research Institutions
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Deoxynucleotide Triphosphates (dNTPs) Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Deoxynucleotide Triphosphates (dNTPs) Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Liquid dNTPs
      9.6.2 Solid dNTPs
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Pharmaceutical
      9.10.2 Research Institutions
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Liquid dNTPs
      10.6.2 Solid dNTPs
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Pharmaceutical
      10.10.2 Research Institutions
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Liquid dNTPs
      11.6.2 Solid dNTPs
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Pharmaceutical
      11.10.2 Research Institutions
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Liquid dNTPs
      12.6.2 Solid dNTPs
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Pharmaceutical
      12.10.2 Research Institutions
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Liquid dNTPs
      13.6.2 Solid dNTPs
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Pharmaceutical
      13.10.2 Research Institutions
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Deoxynucleotide Triphosphates (dNTPs) Market: Competitive Dashboard
   14.2 Global Deoxynucleotide Triphosphates (dNTPs) Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Thermo Scientific
      14.3.2 Merck Millipore
      14.3.3 Promega
      14.3.4 Meridian Bioscience
      14.3.5 Jena Bioscience
      14.3.6 Takara Bio
      14.3.7 NEB
      14.3.8 Geneaid

Our Trusted Clients

Contact Us